All News

The 2013 Arthur D. Smith Endourology Lectureship has been awarded to Thomas Knoll, MD, of University Medical Center Mannheim and the Sindelfingen Medical Center of the University of Tuebingen, Germany.

The AUA said it will launch a national, specialty-wide urologic registry designed to measure and report health care quality and patient outcomes as well as provide data to help identify patterns and trends in the diagnosis and treatment of prostate cancer and eventual outcomes related to treatment options.

The publication of data in the New England Journal of Medicine (2013; 369:1629-37) showing an increase in intensity-modulated radiation therapy utilization among self-referring urologists has reignited the self-referral controversy.

Vitamin D does not appear to increase risk for developing kidney stones, say researchers from the University of California, San Diego.

Many physicians continue to administer the PSA test to even their oldest patients despite the fact that no medical organization recommends routine prostate cancer screening in men older than 75 years of age, according to recently published research.

Researchers at the Duke Cancer Institute in Durham, NC say they have developed a tool to forecast the potential survival of individual prostate cancer patients, enabling physicians to better assess whether to try additional rounds of treatment or seek clinical trials.

The first phase II study to investigate the use of the targeted therapy everolimus (Afinitor) for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease.

Women with common forms of urinary incontinence have various bacteria in their bladder, according to a recent study, and some of these bacteria may differ based on their incontinence type.

In this interview, Dr. Samir S. Taneja discusses the AUA's recommendations on the optimal method to perform a prostate biopsy and handle specimens as well as how to minimize infection and the role of imaging.

Results from a study in an experimental model of cystitis point to the cannabinoid receptor 2 (CB2) as a potential target to develop effective new therapies for patients with painful bladder disorders.

Urinary measurement of inflammatory chemokines may offer a noninvasive method for evaluating treatment response to sacral neuromodulation (InterStim Therapy, Medtronic, Inc., Minneapolis) in patients with interstitial cystitis/painful bladder syndrome, says Michael Chancellor, MD.

Thulium vapoenucleation of the prostate provided significant and durable symptomatic improvement in benign prostatic obstruction, long-term follow-up of a clinical series showed.

Primary androgen deprivation therapy for localized prostate cancer is associated with significantly better survival outcomes in a Japanese cohort compared with an American population, according to a recent study.

In many cases, you have the option of recouping revenue from previous practices/business structures that you no longer report, as long as you can provide the data.

Congratulations to Shlomo Raz, MD, who has been honored by the Confederation Americano de Urologia by naming its highest accolade in his honor and bestowing the first medal on him.

In this article, I examine and question the phenomenon of “the urine drop-off”-having the patient with suspected UTI collect a urine sample at home and drop it off at the practice-in the context of best clinical practice, common sense, and basic office efficiency.

Permanent insurance needs are met through varying types of whole life and universal life insurance policies designed to stay in force throughout one’s lifetime. Unlike term insurance, where premiums generally increase as the insured ages, most permanent life insurance premiums remain level.

"Do I think [ICD-10] will make patient care better? If it did, I would be really shocked. The question is, will it make patient care worse? I hope not.”

Single-fraction radiotherapy for bone metastases from prostate cancer is not widely used despite its comparable efficacy and lower cost in relation to multiple-fraction treatment, according to a recent study.

Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide similar tumor control and decreased late toxicity when compared to surgery, say the authors of a study from the United Kingdom.

While women are far more likely to suffer from urinary tract infections, men are more likely to be hospitalized for treatment, according to a study by urologists from Henry Ford Hospital in Detroit.

MDxHealth SA said its ConfirmMDx for Prostate Cancer test met all of the primary endpoints in a recently completed clinical validation trial.

The group practice of dedicated subspecialists can establish its position as a community center of excellence if it accepts the challenge and the need to modify historic practice concepts.

Data from a phase II study suggest that the potency of sipuleucel-T (Provenge) and immunologic prime-boost responses are maintained when the immunotherapy is administered concurrently or sequentially with abiraterone acetate (ZYTIGA) plus prednisone.

The search is on for drugs based on cannabis.

The latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.

In this interview, Brian R. Matlaga, MD, MPH, discusses factors to consider in the decision to utilize ureteroscopy versus shock wave lithotripsy, how to counsel patients on the optimal approach, how to minimize the morbidity of each modality, and why younger urologists are more likely to perform ureteroscopy.

The bundled payment model for episodes of care is a major player in what could be sweeping changes to the physician payment system that will likely see traditional fee for service taper off. Bundling has already made inroads in some surgical specialties, and it may very well apply to inpatient urologic procedures as well.

This article discusses how urologists can help fill the need for surgical relief work, and offers some advice on ensuring your philanthropic trip is a successful one.

Drugs and devices in the pipeline from Auxilium Pharmaceuticals, Metamark Genetics, Endo Pharmaceuticals, Nymox Pharmaceutical Corp., VIVUS, and Sanofi Chimie.